Description
Description
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors. This 10mg concentration is utilized to study the integrated effects of triple receptor activation on metabolic health and energy expenditure.
Research Applications
Investigations focus on the unique biological synergy of triple pathway modulation in experimental metabolic models.
Reviews
There are no reviews yet.